Ratnaparkhi M, Salvankar S, Tekade A, Kulkarni G
Pharm Nanotechnol. 2024; 13(1):90-116.
PMID: 38265371
DOI: 10.2174/0122117385277725231120043600.
Munawwar A, Sajjad A, Rasul A, Sattar M, Jabeen F
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513898
PMC: 10384399.
DOI: 10.3390/ph16070986.
Vishwasrao H, Master A, Seo Y, Liu X, Pothayee N, Zhou Z
Chem Mater. 2023; 28(9):3024-3040.
PMID: 37405207
PMC: 10317193.
DOI: 10.1021/acs.chemmater.6b00197.
Chavda V, Khadela A, Shah Y, Postwala H, Balar P, Vora L
Nanotheranostics. 2023; 7(4):368-379.
PMID: 37151802
PMC: 10161386.
DOI: 10.7150/ntno.82263.
Wu S, Fan K, Yang Q, Chen Z, Hou Y, Zou Y
J Nanobiotechnology. 2023; 21(1):42.
PMID: 36747202
PMC: 9901004.
DOI: 10.1186/s12951-023-01804-7.
The translational paradigm of nanobiomaterials: Biological chemistry to modern applications.
Sinha A, Simnani F, Singh D, Nandi A, Choudhury A, Patel P
Mater Today Bio. 2022; 17:100463.
PMID: 36310541
PMC: 9615318.
DOI: 10.1016/j.mtbio.2022.100463.
Self-assembled dipeptide based fluorescent nanoparticles as a platform for developing cellular imaging probes and targeted drug delivery chaperones.
Sivagnanam S, Das K, Basak M, Mahata T, Stewart A, Maity B
Nanoscale Adv. 2022; 4(6):1694-1706.
PMID: 36134376
PMC: 9417502.
DOI: 10.1039/d1na00885d.
Metal nanoparticles as a promising technology in targeted cancer treatment.
Xu J, Zhang W, Guo Y, Chen X, Zhang Y
Drug Deliv. 2022; 29(1):664-678.
PMID: 35209786
PMC: 8890514.
DOI: 10.1080/10717544.2022.2039804.
Ex Vivo and In Vivo Evaluation of Dodecaborate-Based Clusters Encapsulated in Ferumoxytol Nanoparticles.
Bernier N, Teh J, Reichel D, Zahorsky-Reeves J, Perez J, Spokoyny A
Langmuir. 2021; 37(49):14500-14508.
PMID: 34843246
PMC: 8761388.
DOI: 10.1021/acs.langmuir.1c02506.
Recent developments in stimuli responsive nanomaterials and their bionanotechnology applications.
Shah R, Frazar E, Hilt J
Curr Opin Chem Eng. 2021; 30:103-111.
PMID: 34307003
PMC: 8300877.
DOI: 10.1016/j.coche.2020.08.007.
Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.
Sharifi-Rad J, Quispe C, Butnariu M, Rotariu L, Sytar O, Sestito S
Cancer Cell Int. 2021; 21(1):318.
PMID: 34167552
PMC: 8223345.
DOI: 10.1186/s12935-021-02025-4.
Magnetic Nanodiscs-A New Promising Tool for Microsurgery of Malignant Neoplasms.
Zamay T, Prokopenko V, Zamay S, Lukyanenko K, Kolovskaya O, Orlov V
Nanomaterials (Basel). 2021; 11(6).
PMID: 34072903
PMC: 8227103.
DOI: 10.3390/nano11061459.
Doxorubicin-Conjugated Iron Oxide Nanoparticles Synthesized by Laser Pyrolysis: In Vitro Study on Human Breast Cancer Cells.
Lungu I, Nistorescu S, Badea M, Petre A, Udrea A, Banici A
Polymers (Basel). 2020; 12(12).
PMID: 33256060
PMC: 7760716.
DOI: 10.3390/polym12122799.
Comprehensive Evaluation of Gene Expression in Negative and Positive Trigger-based Targeting Niosomes in HEK-293 Cell Line.
Barani M, Torkzadeh-Mahani M, Mirzaei M, Nematollahi M
Iran J Pharm Res. 2020; 19(1):166-180.
PMID: 32922478
PMC: 7462495.
DOI: 10.22037/ijpr.2019.112058.13507.
Effects of intraperitoneal injection of magnetic graphene oxide on the improvement of acute liver injury induced by CCl.
Foroutan T, Ahmadi F, Moayer F, Khalvati S
Biomater Res. 2020; 24:14.
PMID: 32864158
PMC: 7449094.
DOI: 10.1186/s40824-020-00192-5.
Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements.
Suciu M, Ionescu C, Ciorita A, Tripon S, Nica D, Al-Salami H
Beilstein J Nanotechnol. 2020; 11:1092-1109.
PMID: 32802712
PMC: 7404288.
DOI: 10.3762/bjnano.11.94.
Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles.
Luther D, Huang R, Jeon T, Zhang X, Lee Y, Nagaraj H
Adv Drug Deliv Rev. 2020; 156:188-213.
PMID: 32610061
PMC: 8559718.
DOI: 10.1016/j.addr.2020.06.020.
Magnetic Nanoparticles Coated with ()-9-Acetoxystearic Acid for Biomedical Applications.
Micheletti G, Boga C, Telese D, Cassani M, Boanini E, Nitti P
ACS Omega. 2020; 5(22):12707-12715.
PMID: 32548454
PMC: 7288358.
DOI: 10.1021/acsomega.0c00163.
Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U, Fakurazi S, Masarudin M, Hussein M
Int J Nanomedicine. 2020; 15:1437-1456.
PMID: 32184597
PMC: 7060777.
DOI: 10.2147/IJN.S236927.
Recent Advancements of Magnetic Nanomaterials in Cancer Therapy.
Mukherjee S, Liang L, Veiseh O
Pharmaceutics. 2020; 12(2).
PMID: 32053995
PMC: 7076668.
DOI: 10.3390/pharmaceutics12020147.
